AAC
Home Help [Feedback] [For Subscribers] [Archive] [Search] --
AAC Accepts, published online ahead of print on 17 December 2007
This Article
Right arrow Full Text (PDF)
Right arrow Other Versions of this Article:
AAC.01569-06v1
52/3/1094    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Line, J. E.
Right arrow Articles by Stern, N. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Line, J. E.
Right arrow Articles by Stern, N. J.

 Previous Article  |  Next Article 

Antimicrob. Agents Chemother. doi:10.1128/AAC.01569-06
Copyright (c) 2007, American Society for Microbiology and/or the Listed Authors/Institutions. All Rights Reserved.

Isolation and Purification of Enterocin E-760 with Broad Antimicrobial Activity Against Gram-positive and Gram-negative Bacteria

J. E. Line*, E. A. Svetoch, B. V. Eruslanov, V. V. Perelygin, E. V. Mitsevich, I. P. Mitsevich, V. P. Levchuk, O. E. Svetoch, B. Seal, G. Siragusa, and N. J. Stern

USDA-ARS, Russell Research Center, Poultry Microbiological Safety Research Unit Athens, GA, U.S.A.; State Research Center for Applied Microbiology and Biotechnology, Obolensk, Russian Federation

* To whom correspondence should be addressed. Email: eric.line{at}ars.usda.gov.


   Abstract

Strain NRRL B-30745, isolated from chicken ceca, and identified as Enterococcus durans/faecium/hirae was initially identified as antagonistic to Campylobacter jejuni. The isolate produced a 5362 Da bacteriocin (enterocin) that inhibits the growth of Salmonella enteritidis, S. choleraesuis, S. typhimurium, S. gallinarum, Escherichia coli O157:H7, Yersinia enterocolitica, Citrobacter freundii, Klebsiella pneumoniae, Shigella dysenteriae, Pseudomonas aeruginosa, Proteus mirabilis, Morganella morganii, Staphylococcus aureus, S. epidermidis, Listeria monocytogenes, Campylobacter jejuni and 20 other Campylobacter spp. isolates. The enterocin, E-760, was isolated and purified by cation exchange and hydrophobic interaction chromatography. The proteinaceous nature of purified enterocin E-760 was demonstrated upon treatment with various proteolytic enzymes. Specifically, the antimicrobial peptide was found to be sensitive to Beta-chymotrypsin, proteinase K and papain, while it was resistant to lysozyme and lipase. The enterocin demonstrated thermostability by retaining activity after 5 min at 100°C and was stable at pH values between 5.0 and 8.7. However, activity was lost below pH 3.0 and above pH 9.5. Administration of enterocin E-760 treated feed significantly (P< 0.05) reduced colonization of young broiler chicks experimentally challenged and colonized with two strains of C. jejuni by more than 8 log10 CFU. Enterocin E-760 also significantly (P<0.05) reduced colonization of naturally acquired Campylobacter spp. in market age broilers when administered in treated feed four days prior to analysis.







Home Help [Feedback] [For Subscribers] [Archive] [Search] --
Clin. Vaccine Immunol. Clin. Microbiol. Rev.
J. Clin. Microbiol. ALL ASM JOURNALS

Copyright © 2007 by the American Society for Microbiology. All rights reserved.